MAPT and Alzheimer disease: IL-6, a key player in the early stages of amyloid plaque formation in the brain of patients with AD (Huell et al., 1995), has also been linked to tau phosphorylation, synapse loss, and cognitive impairment in mouse models of AD (Quintanilla et al., 2004).